Cargando…
In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug–drug interactions
BACKGROUND: Inhibition of cytochrome P450 (CYP) enzymes is the most common cause of harmful drug–drug interactions. The present study aimed at examining the inhibitory effect of the novel antipsychotic drug asenapine on the main CYP enzymes in human liver. METHODS: The experiments were performed in...
Autores principales: | Wójcikowski, Jacek, Danek, Przemysław J., Basińska-Ziobroń, Agnieszka, Pukło, Renata, Daniel, Władysława A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329795/ https://www.ncbi.nlm.nih.gov/pubmed/32219694 http://dx.doi.org/10.1007/s43440-020-00089-z |
Ejemplares similares
-
Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
por: Danek, Przemysław J., et al.
Publicado: (2020) -
The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice
por: Bromek, Ewa, et al.
Publicado: (2022) -
The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions
por: Danek, Przemysław J., et al.
Publicado: (2020) -
The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms
por: Danek, Przemysław J., et al.
Publicado: (2021) -
The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats
por: Haduch, Anna, et al.
Publicado: (2023)